Evan Loh - Oct 28, 2022 Form 4 Insider Report for Paratek Pharmaceuticals, Inc. (PRTK)

Signature
/s/ William M. Haskel, Attorney-in-Fact for Evan Loh
Stock symbol
PRTK
Transactions as of
Oct 28, 2022
Transactions value $
-$30,553
Form type
4
Date filed
11/1/2022, 07:58 PM
Previous filing
Oct 27, 2022
Next filing
Dec 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRTK Common Stock Sale -$30.6K -8.81K -0.68% $3.47 1.28M Oct 28, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover personal income tax obligations upon vesting of performance-based restricted stock units, as previously reported in a Form 4 filed with the Securities and Exchange Commission (the "SEC") on October 27, 2022, pursuant to a Rule 10b5-1 trading plan.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $3.43 to $3.55. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2 to this Form 4.